Sign in

CIK 0001661998

  • Non-accelerated filer
  • Smaller reporting company

Q32 Bio Inc.

Sign in to watch
Ticker
QTTB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473468154
Phone
+1 781-999-0232
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Former names
Q32 Bio Inc., Homology Medicines, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$320,396
in 6 filings

Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-12 LAPORTE KATHLEEN Director Grant or award · Stock Option (Right to Buy) +10,826 10,826
2026-06-12 LAPORTE KATHLEEN Director Grant or award · Stock Option (Right to Buy) +9,810 9,810
2026-01-15 LAPORTE KATHLEEN Director Grant or award · Stock Option (Right to Buy) +23,272 $2.75 $64K 23,272
2025-10-23 LAPORTE KATHLEEN Director Grant or award · Stock Option (Right to Buy) +53,521 53,521
2025-02-24 LAPORTE KATHLEEN Director Returned to the company · Stock Option (Right to Buy) −5,431 0
2025-02-24 LAPORTE KATHLEEN Director Grant or award · Stock Option (Right to Buy) +5,431 5,431
2025-02-24 LAPORTE KATHLEEN Director Returned to the company · Stock Option (Right to Buy) −1,947 0
2025-02-24 LAPORTE KATHLEEN Director Grant or award · Stock Option (Right to Buy) +1,947 1,947
2025-02-24 LAPORTE KATHLEEN Director Returned to the company · Stock Option (Right to Buy) −12,767 0
2025-02-24 LAPORTE KATHLEEN Director Grant or award · Stock Option (Right to Buy) +12,767 12,767
2024-03-25 LAPORTE KATHLEEN Director Grant or award · Stock Option (Right to Buy) +12,767 12,767

Page 1 of 1 · 11 trades